Viewing Study NCT01618695


Ignite Creation Date: 2025-12-24 @ 2:20 PM
Ignite Modification Date: 2026-02-03 @ 10:08 AM
Study NCT ID: NCT01618695
Status: COMPLETED
Last Update Posted: 2021-07-29
First Post: 2012-06-11
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures
Sponsor: Eisai Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: E2007-J000-335
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators